REDWOOD CITY, Calif.,
July 13, 2018 /PRNewswire/
-- Nevro Corp. (NYSE: NVRO), a global medical device company
that is providing innovative, evidence-based solutions for the
treatment of chronic pain, today announced that its management will
be hosting a business update conference call before market open
beginning at 5:30 a.m. Pacific Time
(8:30 a.m. Eastern Time) on
Monday, July 16, 2018.
Investors interested in listening to the conference call may do
so by dialing (866) 393-4306 for U.S. callers or (734) 385-2616 for
international callers (Conference ID: 2196519), or logging into the
webcast on the "Investors" section of the Company's website at
www.nevro.com/investors. Following the call, a replay will be
available on the Investor Events and Presentations webpage of the
Company's website.
About Nevro
Headquartered in Redwood City,
California, Nevro is a global medical device company focused
on providing innovative products that improve the quality of life
of patients suffering from debilitating chronic pain. Nevro has
developed and commercialized the Senza® spinal cord stimulation
(SCS) system, an evidence-based, non-pharmacologic neuromodulation
platform for the treatment of chronic pain. The Senza® system and
Senza II™ system are the only SCS systems that deliver Nevro's
proprietary HF10® therapy. Senza, Senza II, HF10, Nevro and the
Nevro logo are trademarks of Nevro Corp.
Investor Relations Contact:
Nevro Investor
Relations
(650) 433-3247
ir@nevro.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/nevro-to-announce-preliminary-second-quarter-worldwide-revenue-discuss-full-year-2018-revenue-guidance-and-provide-business-updates-300680880.html
SOURCE Nevro Corp.